BEN-MAIMON CAROLE (President and CEO) purchased 1.9% of their position (5K shares) of LARIMAR THERAPEUTICS, INC. on the open market
Open‑market purchase worth $18.5K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/18/2023ACC: 0001062993-23-011546
DirectorOfficer· President and CEO
Since May 2020
+5K
Net shares
Net buyer
$18.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$3.71
Trade value
$18.52K
% of position
1.9%
5/17/2023
261.83K→266.83K
Total
Net shares
+5K
Net value
$18.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/17/2023 | P · Purchase | +5K | $3.71 | $18.52K | 1.9% | 261.83K | 266.83K |
| Total | +5K | $18.52K | ||||||
Derivative Transactions0
No derivative transactions reported